相关实验视频
Updated: Jun 17, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
认知储备的保护作用:对接受深度脑刺激的帕金森病患者进行初步研究
Eleonora Zirone1, Fabiana Ruggiero1, Maria Takeko Molisso1
1Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Journal of clinical medicine
|August 10, 2024
概括
高认知储备 (CR) 可能保护帕金森病 (PD) 患者在深度大脑刺激 (DBS) 后的认知衰退. 较高的CR与STN-DBS手术后更好的长期认知结果有关.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 认知科学 认知科学
背景情况:
- 高认知储备 (CR) 与更好的认知功能和帕金森病 (PD) 中痴呆风险降低有关.
- 在PD患者的下丘脑核深脑刺激 (STN-DBS) 后,CR对长期认知结果的影响需要进一步调查.
研究的目的:
- 评估CR对接受STN-DBS的PD患者长期认知结果的影响.
- 为了确定CR是否可以预测STN-DBS后的认知轨迹.
主要方法:
- 25名PD患者在基线,1年和STN-DBS后5年使用蒙特利尔认知评估 (MoCA) 进行评估.
- 使用认知储备指数问卷测量认知储备,将患者分为低CR (≤130) 和高CR (>130) 组.
主要成果:
- 与低CR组相比,高CR患者在长期随访时显示出明显更好的MoCA得分 (24.5对21.4,p=0.05).
- 高CR组保持了稳定的认知特征,而低CR组在手术后5年显示全球认知下降 (p=0.02).
- 认知能力下降与情绪,人口统计或临床变量无关.
结论:
- 较高的CR似乎是STN-DBS之后的PD患者认知功能的保护因素.
- 高CR可能会减轻与STN-DBS治疗相关的长期认知衰退.
- 评估CR可以为患有认知衰退风险的PD患者提供个性化的术后护理和监测.
更多相关视频
12:04Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
Published on: January 6, 2011
13.0K
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.2K
相关概念视频
Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508